Research

Energy balance

Only 8% of eligible candidates with type 2 diabetes are prescribed GLP-1RA.

Cardiologists should be aware of the low prescription rates of GLP-1RA among eligible patients.

StrongRefutesmedium confidence
Especially GLP-1RA is only used in 8% of eligible candidates with type 2 diabetes.
Pieter Martens et al. · Acta cardiologica. Supplementum · 2022

Why this rating

Based on the review of existing trial data and professional society endorsements.

Source

The use of glucagon-like-peptide-1 receptor agonist in the cardiology practice

Pieter Martens et al. · Acta cardiologica. Supplementum · 2022

DOI 10.1080/00015385.2022.2076307

reviewCited 6×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →